Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.47 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.47 |
| ▸ | F11 | P03951 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | PARP1 | P09874 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1771379 | 0.85 | CA12 (0.60) | CA12CA9CA1CA3CA4 | |
| SCHEMBL5460543 | 0.79 | TNKS2 (0.65) | CA12CA9CA1CA3CA4 | |
| SCHEMBL17951770 | 0.77 | MAPK1 (0.68) | CA12CA9CA1CA3CA4 | |
| SCHEMBL30176791 | 0.74 | CA12 (0.54) | CA12CA9CA1CA3CA4 | |
| SCHEMBL31743074 | 0.74 | F11 (0.74) | CA12CA9CA1CA3CA4 | |
| SCHEMBL30874739 | 0.74 | DAO (0.56) | CA12CA9CA1CA3CA4 | |
| SCHEMBL252706 | 0.74 | CA12 (0.54) | CA12CA9CA1CA3CA4 | |
| SCHEMBL8061721 | 0.74 | CA12 (0.54) | CA12CA9CA1CA3CA4 | |
| SCHEMBL436560 | 0.74 | CA12 (0.74) | CA12CA9CA1CA3CA4 | |
| SCHEMBL708122 | 0.74 | DAO (0.56) | CA12CA9CA1CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285594-A | 7-Aminobenzopyrone or 7-aminoquinolinone compound and application thereof | 浙江大学金华研究院 | 2025-01-10 | — | — | CN | claimed |
| CN-111732573-B | Quinolone acid-aminopyrimidine compound and preparation method and application thereof | 复旦大学 | 2022-09-16 | — | — | CN | claimed |
| CN-111732573-A | Quinolone acid-aminopyrimidine compound and preparation method and application thereof | 复旦大学 | 2020-10-02 | — | — | CN | claimed |
| US-20150157621-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING THE SAME | MARIPOSA HEALTH LTD (AU) | 2015-06-11 | — | — | US | claimed |
| US-8980914-B2 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | MARIPOSA HEALTH LIMITED (AU) | 2015-03-17 | — | — | US | claimed |
| US-20100079635-A1 | OPTICAL ELEMENT WAFER MODULE, OPTICAL ELEMENT MODULE, METHOD FOR MANUFACTURING OPTICAL ELEMENT MODULE, ELECTRONIC ELEMENT WAFER MODULE, METHOD FOR MANUFACTURING ELECTRONIC ELEMENT MODULE, ELECTRONIC ELEMENT MODULE AND ELECTRONIC INFORMATION DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2010-04-01 | — | — | US | claimed |
| CN-1902057-A | Optical recording medium and dye | MITSUBISHI CHEM CORP (JP) | 2007-01-24 | — | — | CN | claimed |
| US-20060235045-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-10-19 | — | — | US | claimed |
| US-20060223003-A1 | Optical recording medium and dye | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-10-05 | — | — | US | claimed |
| EP-1698478-A1 | OPTICAL RECORDING MEDIUM AND DYE | Mitsubishi Chemical Corporation (JP) | 2006-09-06 | — | — | EP | claimed |
| EP-1650191-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD OF TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH THE SAME | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-04-26 | — | — | EP | claimed |
| US-6114352-A | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2000-09-05 | — | — | US | claimed |
| EP-0785190-B1 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK & CHEMICALS (JP) | 2000-08-16 | — | — | EP | claimed |
| US-5942521-A | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1999-08-24 | — | — | US | claimed |
| EP-0785190-A2 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-07-23 | — | — | EP | claimed |
| EP-0374835-B1 | THERMALLY-TRANSFERABLE FLUORESCENT 7-AMINOCARBOSTYRILS | EASTMAN KODAK COMPANY (US) | 1992-11-11 | — | — | EP | claimed |
| EP-0374835-A1 | Thermally-transferable fluorescent 7-aminocarbostyrils | EASTMAN KODAK COMPANY (US) | 1990-06-27 | — | — | EP | claimed |
| US-4891352-A | FOR SECURITY PURPOSES | EASTMAN KODAK COMPANY (US) | 1990-01-02 | — | — | US | claimed |
| JP-6316167-A | — | — | None | — | — | JP | disclosed |
| US-3968119-A | OPTICAL BRIGHTENERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223003-A1 | Optical recording medium and dye | CHRM1, CACNA1S, OXER1 | CA12 1721/4885CA9 1875/4885CA1 521/4885 |
| US-20060235045-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | ELANE, CFTR, ARG2 | CA12 1662/4885CA9 3581/4885CA1 3436/4885 |
| US-20150157621-A1 | THERAPEUTIC AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING THE SAME | ELANE, ARG2, CFTR | CA12 1525/4885CA9 3717/4885CA1 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.